When you’re diagnosed with non-Hodgkin’s lymphoma (NHL), the next step is to find out the stage of your cancer. That tells you how much lymphoma is in your body, where it is, and if it has spread ...
Roche said its Lunsumio drug to combat lymphoma, alongside another medicine, might be effective in earlier treatment lines for forms of the disease.
Stage 2 lymphoma is localized, affecting lymph nodes or a single extranodal site on one diaphragm side, with a favorable prognosis. Diagnosis involves biopsies, blood tests, and imaging to confirm ...
Eli Lilly (LLY) stock is in focus as its Jaypirca cancer drug succeeds in a Phase 3 trial for newly diagnosed patients with ...
Continuous variable modeling such as the Hodgkin lymphoma international prognostic index (A-HIPI) improves prognostic ...
Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the ...
The silver lining here is that I had cancer, which helped me detect my other cancer. It seems crazy to be making that ...
New data show 100% (6/6) objective response rate (ORR) with EO2463 in previously untreated patients with follicular lymphoma needing treatment in combination with rituximab (SIDNEY Cohort 3) -- Of the ...
In this analysis from the phase 3 S1826 study, researchers aimed to show the durability of the efficacy of nivolumab plus doxorubicin, vinblastine, and dacarbazine in classic Hodgkin lymphoma.
New data show 100% (6/6) objective response rate (ORR) with EO2463 in previously untreated patients with follicular lymphoma needing treatment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results